News and History
-

Second $75 million gift from Phil and Penny Knight expands possibilities in care
Read More: Second $75 million gift from Phil and Penny Knight expands possibilities in careOn Feb. 19, 2026, Phil and Penny Knight announced they have given a second transformational gift of $75 million
-

Oregon wastewater dashboard Confirms measles outbreak
Read More: Oregon wastewater dashboard Confirms measles outbreakOn Feb. 19, 2026, a new data tracking tool Oregon Health Authority (OHA) has been launched that shows the five confirmed measles cases identified in the
-

Merck and Mayo Clinic Announce R&D Collaboration Supporting AI-Enabled Drug Discovery and Precision Medicine
Read More: Merck and Mayo Clinic Announce R&D Collaboration Supporting AI-Enabled Drug Discovery and Precision Medicine -

Chemistry-Powered “Breathing” Membrane Opens and Closes Tiny Pores on Its Own
Read More: Chemistry-Powered “Breathing” Membrane Opens and Closes Tiny Pores on Its OwnOn Feb. 18, 2026, researchers at SANKEN, University of Osaka announced using a nanoreactor to produce pores that
-

Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania
Read More: Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania -

Study Shows SARS-CoV-2 RNA found in 39% of hospital air samples during outbreaks, despite good ventilation
Read More: Study Shows SARS-CoV-2 RNA found in 39% of hospital air samples during outbreaks, despite good ventilationOn Feb. 17, 2026, a new study published in Respiratory Medicine show COVID-19 genetic material was frequently detected in
-

Scientists develop first-of-its-kind antibody to block Epstein Barr virus
Read More: Scientists develop first-of-its-kind antibody to block Epstein Barr virusOn Feb. 17, 2026, Fred Hutch Cancer Center scientists announced reaching a crucial milestone in blocking Epstein Barr
-

Danaher Acquires Masimo for $9.9 Billion
Read More: Danaher Acquires Masimo for $9.9 BillionOn Feb. 17, 2026, Danaher announced a definitive agreement to acquire Masimo a leading specialty diagnostics provider of
-

PNNL Powers Biotechnology, Grid Operations, Nuclear Science Through Genesis AI for Science Mission
Read More: PNNL Powers Biotechnology, Grid Operations, Nuclear Science Through Genesis AI for Science MissionOn Feb. 17, 2026, the Department of Energy’s (DOE) Pacific Northwest National Laboratory (PNNL) announces it has joined
-

WHO Issued statement criticizing Ethics of CDC-funded study of hepatitis B vaccine in Guinea-Bissau
Read More: WHO Issued statement criticizing Ethics of CDC-funded study of hepatitis B vaccine in Guinea-BissauOn Feb. 13, 2026, the World Health Organization (WHO) underscores that the hepatitis B birth dose vaccine is
-

EPA revokes scientific finding that underpinned US fight against climate change
Read More: EPA revokes scientific finding that underpinned US fight against climate changeOn Feb. 12 2026, the Trump administration revoked a scientific finding that long has been the central basis
-

South Carolina Reports 13 New Measles Cases, Bringing Outbreak total to 933
Read More: South Carolina Reports 13 New Measles Cases, Bringing Outbreak total to 933 -

Study Finds Declining Perceptions of Safety of Covid-19, Flu, and MMR Vaccines
Read More: Study Finds Declining Perceptions of Safety of Covid-19, Flu, and MMR VaccinesOn Feb. 10, 2026, an Annenberg survey finds that a sizable majority of Americans think the three vaccines
-

NIH scientists develop “digital twin” of eye cells to understand and treat age-related macular degeneration
Read More: NIH scientists develop “digital twin” of eye cells to understand and treat age-related macular degenerationOn Feb. 10, 2026, National Institutes of Health (NIH) researchers announced they have developed a digital replica of
-

Dozens of researchers will move to France from US following high-profile bid to lure talent
Read More: Dozens of researchers will move to France from US following high-profile bid to lure talent -

Lilly to acquire Orna Therapeutics to advance cell therapies for $2.4 billion in cash
Read More: Lilly to acquire Orna Therapeutics to advance cell therapies for $2.4 billion in cashOn Feb. 9, 2026, Eli Lilly and Orna Therapeutics, a biotechnology company dedicated to engineering immune cells in
-

CDC Study Finds Candida auris is an urgent public health threat
Read More: CDC Study Finds Candida auris is an urgent public health threatOn Feb. 9, 2026, a study from Centers for Disease Control and Prevention (CDC) finds Candida auris is
-

Building blocks of life discovered in Bennu asteroid rewrite origin story
Read More: Building blocks of life discovered in Bennu asteroid rewrite origin storyOn Feb. 9, 2026, researchers at Penn State reported that amino acids, the building blocks necessary for life,
-

Genentech’s Fenebrutinib First Investigational Medicine in Over a Decade That Reduces Disability Progression in Multiple Sclerosis
Read More: Genentech’s Fenebrutinib First Investigational Medicine in Over a Decade That Reduces Disability Progression in Multiple SclerosisOn Feb. 7, 2026, Genentech, a member of the Roche Group, announced late-breaking data from the Phase III
-

CDC study highlights growing threat of invasive E coli
Read More: CDC study highlights growing threat of invasive E coliOn Feb. 6, 2026, A study by federal and state health researchers indicates invasive Escherichia coli infections are
